🌟Young Investigator Travel Awards | 33rd ICC🌟 If you plan on submitting an abstract to attend the 33rd International Congress of Antimicrobial Chemotherapy (ICC) in Istanbul, Türkiye (3 - 6 November 2024), consider applying for a Young Investigator Travel Award. Two types of travel awards are available: 1. ISAC YOUNG INVESTIGATOR TRAVEL AWARDS Young investigators from ISAC Member Societies are invited to apply for an ISAC Young Investigator Travel Award. To be eligible, applicants must be under the age of 35 years at the time of the congress and must be the presenting author (poster or oral presentation) and a member of an ISAC Member Society. https://lnkd.in/eh8sMfhP 2. ICC YOUNG INVESTIGATOR REGIONAL TRAVEL AWARDS A number of regional travel awards will be available to young investigators who submit an abstract for the 33rd ICC. To be eligible, applicants from Türkiye and neighbouring countries must be under the age of 35 years at the time of the congress and must be the presenting author (poster or oral presentation). https://lnkd.in/erfxvevZ Apply by 26 July 2024. www.ICC2024.org #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #COVID19 #fungalinfection #globalhealth #clinicalmicrobiology #publichealth #pharmacology #viralinfection #Zoonoses
International Society of Antimicrobial Chemotherapy (ISAC)
Hospitals and Health Care
Aberdeen, Scotland 6,836 followers
ISAC is a federation of member societies aimed at combating antibiotic resistance around the world.
About us
The International Society of Antimicrobial Chemotherapy (ISAC) aims to advance the education and the science of therapy of infection through the establishment of an international federation of affiliated national and regional societies with similar aims and objectives to its own. ISAC currently has a worldwide membership composed of 95 national and regional societies, which in turn have over 50,000 individual members. ISAC promotes the conduct of scientific research, convening international congresses, conferences and symposia and encourages co-operation within the society and between scientists belonging to other societies dealing with related basic and clinical sciences. In the last decade, most of the Society's work has been on antimicrobials. ISAC currently has 22 Working Groups and actively encourages and/or sponsors the formation of international working groups for special research, training projects or the use of therapeutics in the field of anti-infective and anti-neoplastic therapy and coordinating their activities. The Working Groups contribute significantly to the ISAC Disease Management Series of meetings. In addition, the ISAC awards scholarships and bursaries to enable attendance at and travel to its international biennial congresses. The Society’s official journals are the International Journal of Antimicrobial Agents and Chemotherapy (IJAA) and the Journal of Global Antimicrobial Resistance (JGAR). ISAC hosts the International Congress of Antimicrobial Chemotherapy (ICC) worldwide every second year. For more information, email [email protected] Visit the ISAC-Academy - a free e-learning resource hosting content from ISAC, its Member Societies and organisations with common interests. www.ISAC-Academy.world
- Website
-
http://ISAC.world
External link for International Society of Antimicrobial Chemotherapy (ISAC)
- Industry
- Hospitals and Health Care
- Company size
- 2-10 employees
- Headquarters
- Aberdeen, Scotland
- Type
- Nonprofit
- Founded
- 1961
- Specialties
- antibiotics, antibiotic resistance, antimicrobial stewardship, infectious diseases, antimicrobial agents, antimicrobials, microbiology, COVID, Infection control, infection prevention, society, public health, and global health
Locations
-
Primary
Aberdeen, Scotland AB25 2NZ, GB
Employees at International Society of Antimicrobial Chemotherapy (ISAC)
-
Andreas Voss
Professor and Chair, Medical Microbiology and Infection Control, UMCG
-
Rehab El-Sokkary
Medical microbiologist, Change leader, Infection Prevention Expert, Clinical Researcher
-
Nusaibah Abdul Rahim
Deputy Dean (Development), Faculty of Pharmacy, Universiti Malaya
-
Hafiz Abdul Aziz
A clinician-scientist in academia interested in clinical pharmacokinetics & therapeutic drug monitoring
Updates
-
🌟Invitation to attend the 33rd ICC 🌟 We are extremely honoured to have Prof. Gunnar Kahlmeter as a speaker at the 33rd International Congress of Antimicrobial Chemotherapy (ICC). This year, Prof, Kahlmeter will be presented with the Umezawa Memorial Award (HUMA), the most prestigious award given by the International Society of Antimicrobial Chemotherapy (ISAC) for his outstanding career in antimicrobial chemotherapy. In this video, Prof. Kahlmeter also shares fond memories of his longstanding association with ISAC - the first scientific lecture he ever presented was at the 8th ICC in 1975. It is fitting that now, at the age of 75, Prof. Kahlmeter will present the opening lecture at the 33rd ICC on "The quirks of the EUCAST susceptibility testing system". Join Prof. Kahlmeter in the beautiful city of Istanbul this November! Watch this short video⬇ https://lnkd.in/eqV8Ea-v #antimicrobialresistance #infectiousdieases #antibiotics #antibioticresistance #superbugs #infectiousdisease #clinicalmicro #healthcare #antimicrobialstewardship #antimicrobials #clinicalmicrobiology #globalhealth #publichealth #EUCAST
-
-
🌟LIVE | ABX Guide global launch🌟 The panel discussion / Q&A session on the ABX Guide and the presentations from Mike Sharland and Paul Newton is underway. There is still time to ask your questions⬇ https://lnkd.in/eat9Hzmh #superbugs #infectiousdisease #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth
-
-
🌟LIVE | ABX Guide global launch🌟 Prof. Paul Newton, an infectious disease doctor and Professor of Tropical Medicine in the Centre for Tropical Medicine & Global Health, Oxford University, is giving an excellent presentation on the quality of antibiotics and their potential impact on patient outcome and AMR. Following this presentation, there will be a panel discussion and a Q&A session - join in⬇ https://lnkd.in/eat9Hzmh #superbugs #infectiousdisease #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth
-
-
🌟LIVE | ABX Guide global launch🌟 Next up, Prof. Mike Sharland, a leading global expert in antibiotic use and policy, is giving an excellent presentation on the WHO AWaRe Book which he co-authored. Join in and hear from the experts⬇ https://lnkd.in/eat9Hzmh #superbugs #infectiousdisease #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth
-
-
🌟LIVE | ABX Guide global launch🌟 Dr Hind Kadri is giving a concise overview of how the ABX Guide came to fruition from the initial stakeholder survey stage to the ABX Guide webinar series. There is still time to register⬇ https://lnkd.in/eat9Hzmh #superbugs #infectiousdisease #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth
-
-
🌟LIVE | ABX Guide global launch🌟 The global webinar to launch the ABX Guide has started. Prof. Heiman Wertheim is speaking on the importance of this guide - currently there are no up to date guidelines available in LMICs and no directed antibiotic therapy guidelines... Find out more about this vital and free initiative. There is still time to register⬇ https://lnkd.in/eat9Hzmh #superbugs #infectiousdisease #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth
-
-
🌟Happening today | ABX Guide global launch🌟 The global webinar to launch the ABX Guide starts in less than 90 minutes. There is still time to register⬇ https://lnkd.in/eat9Hzmh Don't miss this opportunity to hear about this new global initiative - a free-access web-based pathogen-directed treatment guideline for antimicrobial use in resource-constrained settings. As well as details of this project, you will hear from Prof. Mike Sharland and Prof. Paul Newton, two experts in the field of antimicrobial stewardship and resistance. 3 September @ 12.00 - 13.30 (CET) This series of webinars will delve into the relevance of the ABX Guide and the development process behind its treatment recommendations. We will explore its application across various geographic regions, featuring speakers who will highlight related projects and initiatives. Join us to engage with experts and stakeholders in the field, and contribute to advancing global health through informed antibiotic stewardship. The first webinar is the for the global launch of the guide and the other webinars are being held across different regions with presentations tailored to each region. #superbugs #infectiousdisease #clinicalmicro #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth #pathogen #bacteria #LMIC
-
-
🌟Happening tomorrow | ABX Guide global launch🌟 The global webinar to launch the ABX Guide is happening tomorrow. Don't miss this opportunity to hear about this new global initiative - a free-access web-based pathogen-directed treatment guideline for antimicrobial use in resource-constrained settings. As well as details of this project, you will hear from Prof. Mike Sharland and Prof. Paul Newton, two experts in the field of antimicrobial stewardship and resistance. 3 September @ 12.00 - 13.30 (CET) Places are limited so don't forget to register REGISTER NOW⬇ https://lnkd.in/eat9Hzmh This series of webinars will delve into the relevance of the ABX Guide and the development process behind its treatment recommendations. We will explore its application across various geographic regions, featuring speakers who will highlight related projects and initiatives. Join us to engage with experts and stakeholders in the field, and contribute to advancing global health through informed antibiotic stewardship. The first webinar is the for the global launch of the guide and the other webinars are being held across different regions with presentations tailored to each region. #superbugs #infectiousdisease #clinicalmicro #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth #pathogen #bacteria #LMIC
-
-
Today is your last chance to apply for an ISAC Project Grant for up to £15,000. Research projects involving low- to middle- income countries is invited by the end of today. https://lnkd.in/erkUG46
🌟One day to apply | ISAC Project Grants🌟 The deadline to apply for an ISAC Project Grant is tomorrow - 1 September. Don't miss this excellent opportunity to apply for up to £15,000 for research involving low- to middle- income countries. Applicants are required to demonstrate that ISAC funds will be utilised for a clearly defined piece of research, which will have an identifiable outcome on completion of the work. At least one applicant must be from a low- to middle- income country. Research projects should address one of the three following areas: • What are feasible and effective prevention strategies to prevent transmission of (resistant) pathogens in low resource settings? • What basic laboratory support does a healthcare system minimally need to tackle infectious diseases? • How do we improve antimicrobial use worldwide to ensure it is delivered only to those who need it? ELIGIBILITY • Principal applicant must be a member of an ISAC Member Society. Visit the website to see the full list of ISAC Member Societies. Any relevant society which is not a member can apply to join - find out more here. Once the society’s application has been approved, members can apply for Project Grants. • The other applicants do not need to be a member of an ISAC Member Society. • The principal applicant must be the principal investigator on the intended research. • At least one investigator must be from a low- to middle- income country. • At least two countries must be involved. DEADLINE: 1 September 2024 Visit the ISAC website for more details ⬇ https://lnkd.in/erkUG46 #clinicalmicro #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobials #antimicrobialresistance #fungalinfection #clinicalmicrobiology #globalhealth #publichealth #viralinfection #infectiousdisease #LMIC #grants #superbugs
-